Intracranial Aneurysm Market To Reach $2.74 Billion By 2030

Intracranial Aneurysm Market Growth & Trends

The global intracranial aneurysm market size is anticipated to reach USD 2.74 billion in 2030 and is projected to grow at a CAGR of 9.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of the market is attributed to various factors, such as increased cases of stroke, increasing incidence of people suffering from cerebrovascular disorders, and continuous product launches by key players. Furthermore, the market is growing rapidly in developing nations with expanding disposable income levels and improved access to healthcare. Currently, the cause of brain aneurysms is not clearly understood. However, there are various factors linked to this condition, including aging, brain trauma, hereditary, high blood pressure, atherosclerosis, infections, and a sedentary lifestyle. Notable symptoms encompass cranial nerve dysfunction, localized headaches, and double vision.

Consequently, the growing population of individuals afflicted with intracranial aneurysms is contributing to the market expansion. Businesses in this field are always looking for ways to make existing therapies safer and more effective while also introducing new technologies, which are anticipated to increase the demand for intracranial aneurysm products globally. For instance, in June 2022, Pipeline Vantage with Shield Technology, a fourth-generation flow deflector with a CE mark by India Medtronic, was developed for endovascular therapy for cerebral aneurysms. A newly developed flow deflector, Pipeline Vantage, features Shield technology and has enhanced features of the design for both the delivery system and the implant. By developing a scaffold that promotes the development of cells in the innermost layer of the target blood vessel, these qualities make it easier and more reliable for doctors to deliver, deploy, and repair brain aneurysms and intracranial aneurysms.

 Request a free sample copy or view report summary: Intracranial Aneurysm Market Report

Intracranial Aneurysm Market Report Highlights

• The global market has experienced a significant degree of innovation, with innovations in both endovascular devices and delivery systems.

• The endovascular coiling segment led the market with the largest revenue share of 72.4% in 2024. The endovascular coiling technique is a minimally invasive procedure that employs a catheter to identify and treat aneurysms in the brain.

• The flow diverters segment is expected to grow at the fastest CAGR of 13.4% over the forecast period. The continuous evolution of flow diverter technology boosts the market growth.

• The hospital segment dominated the global intracranial aneurysm market and accounted for the largest revenue share of 88.9% in 2024.

• North America intracranial aneurysm market dominated the global market and accounted for the largest revenue share of 27.6% in 2024 owing to the presence of well-established healthcare infrastructure, the rising geriatric population, and the high incidence of hypertension and stroke.

Intracranial Aneurysm Market Segmentation

Grand View Research has segmented the global intracranial aneurysm market report based on type, end use, and region:

Intracranial Aneurysm Type Outlook (Revenue, USD Million, 2018 - 2030)

• Surgical Clipping

• Endovascular Coiling

• Flow Diverters

• Others

Intracranial Aneurysm End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals

• Clinics

• Others

Intracranial Aneurysm Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • UK

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • Thailand

  • South Korea

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players of Intracranial Aneurysm Market

• Medtronic plc

• Stryker Corporation

• MicroPort Scientific Corporation.

• Johnson & Johnson Services, Inc.

• MicroVention Inc.

• B. Braun Melsungen AG

• Integra LifeSciences

• RAUMEDIC AG

• Terumo Corporation

• Delta Surgical